comparemela.com

Latest Breaking News On - Ameritas investment partners inc - Page 8 : comparemela.com

CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Reaffirmed by Truist Financial

Truist Financial reaffirmed their buy rating on shares of CARGO Therapeutics (NASDAQ:CRGX – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $32.00 target price on the stock, down from their prior target price of $34.00. Separately, Jefferies Financial Group boosted their price objective on CARGO Therapeutics […]

California
United-states
American
Therapeutics-company-profile
American-international-group-inc
Nasdaq
Jefferies-financial-group
Therapeutics-inc
Ameritas-investment-partners-inc
Truist-financial
Free-report

Wave Life Sciences (NASDAQ:WVE) Coverage Initiated at Wells Fargo & Company

Wells Fargo & Company started coverage on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a report released on Wednesday, MarketBeat.com reports. The firm issued an overweight rating and a $11.00 price target on the stock. Other analysts have also recently issued research reports about the stock. StockNews.com cut shares of Wave Life […]

Switzerland
Canada
Swiss
Kyle-moran
Royal-bank
Swiss-national-bank
Securities-exchange-commission
Jamesj-burns-company
Ameritas-investment-partners-inc
Capstone-investment-advisors
Wells-fargo-company
Wave-life-sciences

Needham & Company LLC Increases Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $18.00

Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price objective upped by Needham & Company LLC from $16.00 to $18.00 in a research report released on Wednesday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the company. The […]

Arcutis-biotherapeutics
Masaru-matsuda
Pricet-rowe-associates-inc
Deutsche-bank
Ameritas-investment-partners-inc
Needham-company
Arcutis-biotherapeutics-inc
Goldman-sachs-group
Proshare-advisors
Securities-exchange-commission
Free-report
Moderate-buy

Cullinan Oncology, Inc. (NASDAQ:CGEM) Given Average Rating of "Buy" by Analysts

Shares of Cullinan Oncology, Inc. (NASDAQ:CGEM – Get Free Report) have been given a consensus rating of “Buy” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have issued a report […]

China
United-states
Jennifer-michaelson
Stifel-nicolaus
Pricet-rowe-associates-inc
Mirae-asset-global-investments-co
Nasdaq
Ameritas-investment-partners-inc
Cullinan-oncology-inc
China-universal-asset-management-co
Parkman-healthcare-partners
Securities-exchange-commission

Squarespace, Inc. (NYSE:SQSP) Receives $40.62 Average PT from Brokerages

Squarespace, Inc. (NYSE:SQSP – Get Free Report) has received a consensus rating of “Hold” from the sixteen analysts that are currently covering the firm, Marketbeat reports. Nine investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month target price among brokers that […]

Canada
United-states
Paul-gubbay
Robertw-baird
Anthony-casalena
Securities-exchange-commission
Squarespace-inc
Sunbelt-securities-inc
International-assets-investment-management
Barclays
Ameritas-investment-partners-inc
Squarespace-company-profile

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.